Topics

Industry raises concerns with FDA guidance on post-inspection feedback

07:06 EDT 29 Apr 2019 | SmartBrief

AdvaMed and other stakeholders have raised concerns with the FDA's draft guidance on requesting feedback on Form 483 citation -More

Original Article: Industry raises concerns with FDA guidance on post-inspection feedback

NEXT ARTICLE

More From BioPortfolio on "Industry raises concerns with FDA guidance on post-inspection feedback"

Quick Search